Stay ahead of emerging resistance

the trusted way.

For more than 30 years, MicroScan
Systems have been exclusively focused
on ID/AST testing, offering unmatched
experience, expertise, and technical
support to help guide physicians and
improve patient care.
MicroScan Dried Overnight Gram
Positive Panels from Siemens now
continue a tradition of quality and
innovation. They are designed to help
keep your laboratory staff at the
forefront of identification and
susceptibility testing and are compatible
with all MicroScan instruments.

Versatility for your unique

testing needs.
Experience flexibility and choice
through dynamic MicroScan menu
options designed to streamline testing
and help boost your efficiency.
Manage changing formulary needs
with a broad antimicrobic menu and
more than 95 MicroScan panel
choices (available globally)
Select ID-only, AST-only, and
ID/AST combination panels for
workflow flexibility

Provide clinically relevant

identification from an extensive
database of gram-positive
microorganisms

Utilize a one-panel format for all

Siemens microbiology instruments
for simplified testing procedures and
streamlined workflow

Detect inducible clindamycin

resistance on all Staphylococcus
species (98.7% category agreement
to reference method)

Perform and interpret tests manually

or on MicroScan instrumentation

Enhance accuracy of MRSA

detection using integrated cefoxitin
screen (98.7% category agreement
to reference method)

First-time accuracy
The MicroScan system uses a growth-based, non-ID-dependent direct
testing method, which allows for better detection of emerging resistance.
The system does not rely on historical data: It provides a real-time
advantage for accuracy and uses direct MIC* technology to detect
emerging and low-level resistance. This means fewer confirmatory
tests are needed, providing you with accurate results the first time.
This functionality aligns with most CLSI guidelines to improve detection
of resistance mechanisms without additional confirmation tests.

Siemens Healthcare Diagnostics, a global leader

in clinical diagnostics, provides healthcare
professionals in hospital, reference, and physician
office laboratories and point-of-care settings with
the vital information required to accurately
diagnose, treat, and monitor patients. Our
innovative portfolio of performance-driven
solutions and personalized customer care
combine to streamline workflow, enhance
operational efficiency, and support improved
patient outcomes.
MicroScan is a trademark of Siemens Healthcare
Diagnostics Inc.
Not available for sale in the U.S.
Product availability may vary from country to
country and is subject to varying regulatory
requirements. Please contact your local
representative for availability.
Order No. A91DX-MM-131348-GC1-4A00
11-2013 | All rights reserved
2013 Siemens Healthcare Diagnostics Inc.

Aligns
with most
EUCAST
guidelines

Global Division
Siemens Healthcare Diagnostics Inc.
511 Benedict Avenue
Tarrytown, NY 10591-5005
USA
www.siemens.com/diagnostics

www.siemens.com/microbiology
Global Siemens Headquarters
Siemens AG
Wittelsbacherplatz 2
80333 Muenchen
Germany

Global Siemens Healthcare

Headquarters Siemens AG
Healthcare Sector
Henkestrasse 127
91052 Erlangen
Telephone: + 49 9131 84-0
Germany
www.siemens.com/healthcare

Your First Choice in

Resistance Detection
MicroScan Gram Positive
Conventional Panels

*Minimum inhibitory concentration

www.siemens.com/diagnostics

Answers for life.

Panel Definitions

Panel Name

Pos Staph
Combo 30

Pos Strep
Combo 36

Pos
Combo 35

Pos
Combo 37

Pos
Combo 38

Pos
Combo 42

Pos BP
Combo 32

Pos BP
Combo 33

Pos MIC 31

Pos MIC 32

Pos MIC 33

SMN

10460351

10479096

10479093

10479102

10479103

10713829

10479094

10479106

10479099

10479107

10713828

Legacy Catalog Number

B1016 135

B1016 154

B1016 151

B1016 160

B1016 161

B1016 174

B1016 152

B1016 164

B1016 157

B1016 165

B1016 173

Languages

FR

E, FR, NO

E, FR, GR, NO, PL

E, ES, GR, PL, PT

E, ES, GR, PL, PT

DE, E, ES, FR,

GR, IT, PL, PT, TR

DE, E, GR, IT,

NO, PL

DE, E, FR, GR,

IT, NO, PL

E, FR, NO

DE, E, FR, GR,

IT, NO, PL

DE, E, ES, FR, GR,

IT, PL, PT, TR

Abbr.

Antimicrobic Agent

g/mL

g/mL

g/mL

g/mL

g/mL

g/mL

g/mL

g/mL

g/mL

g/mL

g/mL

Abbr.

Ak
Aug
Am
Azi
Cpe
Cft
CfxS
Cpt
Crm
Cf
C
Cp
Cla
Cd
Dap
Etp
E
Fos
FA
Gm
GmS
Imp
ICd
K
KS
Lvx
Lin
Lzd
Mer
Min
Mxf
Mup
Nt
Fd
Nxn
Ofl
Ox
P
Prs
Rif
StS
Syn
Tei
Te
To
T/S
Va

Amikacin
Amoxicillin/K Clavulanate
Ampicillin
Azithromycin
Cefepime
Cefotaxime
Cefoxitin Screen
Ceftaroline
Cefuroxime
Cephalothin
Chloramphenicol
Ciprofloxacin
Clarithromycin
Clindamycin
Daptomycin
Ertapenem
Erythromycin
Fosfomycin
Fusidic Acid
Gentamicin
Gentamicin Synergy Screen
Imipenem
Inducible Clindamycin Test
Kanamycin
Kanamycin Synergy Screen
Levofloxacin
Lincomycin
Linezolid
Meropenem
Minocycline
Moxifloxacin
Mupirocin
Netilmicin
Nitrofurantoin
Norfloxacin
Ofloxacin
Oxacillin
Penicillin
Pristinamycin
Rifampin
Streptomycin Synergy Screen
Synercid
Teicoplanin
Tetracycline
Tobramycin
Trimethoprim/Sulfamethoxazole
Vancomycin

1 4

1 8
32
2, 16
1 4

4/0.5
2 16

1 8
1 4

4, 256

32 64

1 4
0.25 2
0.25 1, 16
0.5 2
0.5 1, 4, 16

0.25 2
1 8
4 8
1 2
2/38, 8/152
1 8

0.12 8

0.5, 16

8 16

0.25 2

0.25 4

500
1 2

1,000
1 4
1 8
0.5 4

0.5 2

64

0.03,0.12 0.25,2
1 2
0.5, 4, 16
1,000
1 4
1 8
1 8

1/19 2/38
1 8

8 16

1 8
1 2

8 16
0.5 2

0.25 2
1 4

0.5 2

2, 16
1 4
500

4/0.5

1 4

1 4

0.5 1
4 8, 256

64

0.25 2
0.03,0.12 0.25,2

1 2
1,000
1 4
2 8
1 2

0.5 8

8 32
4/2 8/4

0.5 2

0.25 2
0.5 4

0.5 4
32 64
2, 16
1 4

4/0.5

1 4

1 4

4 8, 256

32 64

0.25 2
0.03,0.12 0.25

0.5 2

1 8
1 2
1 2
1/19 4/76
0.5 8

1 8

0.5 2

0.25 2
0.25 4

0.25 4
32 64

1 2
500

4/0.5

1 4

1 4

32 64

0.25 2
0.03,0.12 0.25,2,8

1,000
1 4
1 8
1 8

1/19 4/76
0.25 8

4/2 8/4
0.25, 4 8

4
0.5 1

1 2

0.25 2
1 4

0.5 4
32 64

1, 4 8
500

4/0.5

1 4

2 4

256

32 64

0.25 2
0.12 0.25
1 2

1,000
1 4
2 16
1 8
1, 4 8
2/38 4/76
1 16

4/2 8/4
4 8

8 16
8 16
1 2
1 2
0.25 0.5, 2
1, 4

1 2
32
2, 16
1 2
500

4/0.5

1 4

2 4

0.5 1

2 4
32 64
4 8

0.25, 1 2
0.03 0.12, 8

1 2
1,000
1 4
1 8
1 2

2/38 4/76
0.5 8

2/1 8/4
2 8
1 2

8
0.5 1

0.25 0.5, 2
1 4

1 2
32
2
1 4
500
2 8
4/0.5

1 2

2 4

0.5 1
4 8, 256

64

0.25 2
0.12 0.25, 2

1 2
1,000
1 4
2 8
1 2

1/19 4/76
0.5 8

0.12 8

0.5, 16
4

8 16

0.25 2
1

0.25 4
32
2
1
500
1 2
4/0.5
4 16
1,000
0.5 4
1 8
0.5 4

1
0.5 2
4 8

64

0.5 4
0.25 2
0.03 0.25, 2
1 2
0.5, 4 16
1,000
0.5 4
1 8
1 8
1
1/19 4/76
1 8

0.5/0.25 8/4
0.5 8
1 2
4 8
1 2
4

4 8

8
0.5 1

0.25 0.5, 2
0.5 4
0.5 1
1 2
32
2
1 4
500
2 8
4/0.5

1 2

0.5 4
28

0.5 1
4 8, 256

64

0.25 2
0.03 0.25, 2

0.5 2
1,000
1 4
1 8
1 2
1 4
1/19 4/76
0.25 8

8 32
4/2 8/4
0.25, 4 8

4
0.5 1

8 16
1 2

0.25 2
1 4

0.5 4
32 64
2
1 8
500
4 8
4/0.5

1 4

1 4

1 8
0.5 1
256

32 64
4 8

0.25 2
0.12 0.25, 8
1 2
0.5 2
1,000
1 4
1 16
1 8
1 8
2/38 4/76
0.25 16

Ak
Aug
Am
Azi
Cpe
Cft
CfxS
Cpt
Crm
Cf
C
Cp
Cla
Cd
Dap
Etp
E
Fos
FA
Gm
GmS
Imp
ICd
K
KS
Lvx
Lin
Lzd
Mer
Min
Mxf
Mup
Nt
Fd
Nxn
Ofl
Ox
P
Prs
Rif
StS
Syn
Tei
Te
To
T/S
Va

Total Antimicrobics/Panel

23

22

26

23

21

26

30

29

34

35

34

Pos Staph Combo: Provides

gram-positive identification
and susceptibility results on one
panel. Drug selection provides
staphylococci coverage, as well
as urine and systemic reporting.
Pos Strep Combo: Provides
gram-positive identification
and susceptibility results on one
panel. Drug selection provides
streptococci coverage, as well
as urine and systemic reporting.
Pos Combo: Provides grampositive identification and
susceptibility results on one
panel. Drug selection provides
both staphylococci and
enterococci coverage, as well as
urine and systemic reporting.
Pos BP Combo: Provides grampositive identification and
susceptibility results on one
panel. Drug selection provides
both staphylococci and
enterococci coverage, as well as
urine and systemic reporting.
Panel contains shorter dilutions
around the breakpoints, allowing
for a broader drug menu.
Pos MIC: Provide gram-positive
susceptibility results only and
longer dilution schemes for better
detection of emerging resistance.
Drug selection provides both
staphylococci and enterococci
coverage, as well as urine and
systemic reporting.
Not for sale in the U.S., China, or Japan

Legend:
DE German
E English
ES Spanish
FR French
GR Greek
IT Italian
NO Norwegian
PL Polish
PT Portuguese
TR Turkish